Both in Pharmaceuticals
Protagonist Therapeutics vs TG Therapeutics
Over the past year PTGX returned +87.4% and TGTX returned +82.3%; their daily moves had a correlation of 0.37.
PTGX +87.4% TGTX +82.3%Growth of $1, one year, split-adjusted
| Metric | PTGX | TGTX |
|---|---|---|
| Price | $143.37 | $61.63 |
| Market cap | $9.28B | $9.43B |
| Today | +2.23% | +1.45% |
| 1 month | +3.4% | +18.1% |
| 6 months | +37.9% | +46.8% |
| Year to date | +64.2% | +106.7% |
| 1 year | +88.8% | +82.9% |
| Revenue growth (YoY) | +3749.2% | +70.3% |
| Gross margin | 100.0% | 82.9% |
| Net margin | 76.3% | 3.2% |
| P/E (TTM) | 111.9× | 21.4× |
| Price / sales | 32.9× | 11.8× |
| Net cash | $782.6M | -$193.1M |
| Dividend yield | — | — |
| Volatility (60d) | 32.0% | 36.8% |
| Short % of float | 16.8% | 20.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).